Rentiapril

This classification denotes an ace inhibitor with the molecular formula C13H15NO4S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier D0TAM1017B, chemically known as 4-thiazolidinecarboxylic acid, 2-(2-hydroxyphenyl)-3-(3-mercapto-1-oxopropyl)-, (2r-cis)- but generally known as rentiapril, which bears US NIH Compound Identifier 71244. European Medicines Agency schedules Rentiapril in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10277MIG. The term RENTIAPRIL is an International Non-Proprietary Name. RENTIAPRIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule rentiapril under HS 29341000 and SITC 51579. As of Q4 2014, RENTIAPRIL remains the US FDA Preferred Term for this commodity. Rentiapril bears US NLM identifiers UMLS ID C0073061 and NCI Concept Code C72912. SMILES: S1C(N(C(C1)C(=O)O)C(=O)CCS)c1c(O)cccc1.